{"schema_version":"secwatch.filing_event.v1","accession":"0001964738-25-000049","form_type":"8-K","ticker":"SOLV","cik":"0001964738","company_name":"Solventum Corp","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.584665+00:00","generated_at":"2026-05-22T05:47:30.679492+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Solventum Q1 sales up 4.3% organic; GAAP EPS $0.78, adjusted EPS $1.34; guides FY organic growth higher","bullets":["Net sales $2.07B (+2.6% reported, +4.3% organic); net income $137M (-42.2% YoY).","GAAP diluted EPS $0.78 vs $1.37; adjusted diluted EPS $1.34 vs $2.08.","Operating cash flow $29M (down 93.4%); free cash flow -$80M vs $340M prior year.","Raised FY 2025 organic sales growth outlook by 50bps to +1.5% to +2.5%.","Adjusted operating income margin fell 430bps to 19.7% due to lower gross margins and stand-up costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001964738-25-000049","json":"https://secwatch.observer/filing/0001964738-25-000049.json","markdown":"https://secwatch.observer/filing/0001964738-25-000049.md","text":"https://secwatch.observer/filing/0001964738-25-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000049/0001964738-25-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000049/solv-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T05:47:30.679492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}